Efficacy and Safety of Albendazole in Hookworm-infected Preschool-aged Children, School-aged Children, and Adults in Côte d’Ivoire: A Phase 2 Randomized, Controlled Dose-finding Trial

BACKGROUND: Infections with hookworms affect about half a billion people worldwide. Recommended therapy includes 400 mg of albendazole, which is moderately efficacious. Higher doses have been rarely assessed. METHODS: A randomized, controlled dose-finding trial was conducted in Côte d’Ivoire with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Chandni, Coulibaly, Jean T, Hofmann, Daniela, N’Gbesso, Yves, Hattendorf, Jan, Keiser, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282316/
https://www.ncbi.nlm.nih.gov/pubmed/32668456
http://dx.doi.org/10.1093/cid/ciaa989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282316/
https://www.ncbi.nlm.nih.gov/pubmed/32668456
http://dx.doi.org/10.1093/cid/ciaa989

Ejemplares similares